Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Altered factor VII activity in hemophilia.

B C Miller, M B Hultin, J Jesty

    Blood
    |April 1, 1985
    PubMed
    Summary

    Hemophilic plasma shows lower activated factor VII (FVIIc-B) levels compared to normal plasma. This suggests factor VII is less activated in hemophilia, potentially impacting bleeding tendencies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cook County Hospital, Chicago, Ills.: Rupture of Urethra-Cystotomy-Cured. Service of Dr. Edwin Powell.

    The Chicago medical journal·2023
    Same author

    Primary prevention of adolescent pregnancy: Promoting family involvement through a school curriculum.

    The journal of primary prevention·2013
    Same author

    Educational correlates of adolescents' sexual attitudes and behavior.

    Journal of youth and adolescence·2013
    Same author

    Sexual attitudes and behavior of high school students in relation to background and contextual factors.

    Journal of sex research·2012
    Same author

    Cholera as it Prevailed in Chicago, in 1873.

    Public health papers and reports·2009
    Same author

    von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

    Haemophilia : the official journal of the World Federation of Hemophilia·2008

    Area of Science:

    • Hematology
    • Biochemistry
    • Hemostasis

    Background:

    • Factor VII is a crucial component of the extrinsic pathway of coagulation.
    • Hemophilia A and B are inherited bleeding disorders characterized by deficiencies in intrinsic pathway factors.
    • The activation state of Factor VII in hemophilic plasma is not well understood.

    Purpose of the Study:

    • To investigate and compare Factor VII levels and activation states in hemophilia A and B plasmas versus normal controls.
    • To evaluate the sensitivity of different Factor VII assay methods to Factor VII activation.

    Main Methods:

    • A prospective study comparing hemophilic and normal plasma using three Factor VII assays: standard clotting (FVIIc-A), modified clotting (FVIIc-B), and amidolytic assays.
    • FVIIc-B assay was hypothesized to be more sensitive to Factor VIIa.
    • Ex vivo activation experiments were conducted to confirm assay sensitivity.

    Main Results:

    • The FVIIc-B assay revealed significantly lower Factor VII activity in hemophilic plasmas (68.2%) compared to normal plasmas (83.5%).
    • The amidolytic assay, measuring total Factor VII, showed higher levels in hemophilic plasmas (126.9%) than in normal plasmas (99.4%).
    • The FVIIc-A assay results closely mirrored the amidolytic assay, indicating insensitivity to Factor VII activation state.

    Conclusions:

    • The modified clotting assay (FVIIc-B) is more sensitive to Factor VII activation than standard clotting (FVIIc-A) or amidolytic assays.
    • Factor VII appears to be less activated in hemophilic plasma compared to normal plasma.
    • This reduced Factor VII activation may offer insights into the hemostatic balance in hemophilia, though its direct contribution to bleeding diathesis remains unknown.

    Related Experiment Videos